Cargando…
High Throughput Viability Assay for Microbiology
Counting viable cells is a universal practice in microbiology. The colony forming unit (CFU) assay has remained the gold standard to measure viability across disciplines; however, it is time-intensive and resource-consuming. Herein, we describe the Geometric Viability Assay (GVA) that replicates CFU...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881960/ https://www.ncbi.nlm.nih.gov/pubmed/36712102 http://dx.doi.org/10.1101/2023.01.04.522767 |
_version_ | 1784879214844968960 |
---|---|
author | Meyer, Christian T. Lynch, Grace K. Stamo, Dana F. Miller, Eugene J. Chatterjee, Anushree Kralj, Joel M. |
author_facet | Meyer, Christian T. Lynch, Grace K. Stamo, Dana F. Miller, Eugene J. Chatterjee, Anushree Kralj, Joel M. |
author_sort | Meyer, Christian T. |
collection | PubMed |
description | Counting viable cells is a universal practice in microbiology. The colony forming unit (CFU) assay has remained the gold standard to measure viability across disciplines; however, it is time-intensive and resource-consuming. Herein, we describe the Geometric Viability Assay (GVA) that replicates CFU measurements over 6-orders of magnitude while reducing over 10-fold the time and consumables. GVA computes a sample’s viable cell count based on the distribution of embedded colonies growing inside a pipette tip. GVA is compatible with gram-positive and -negative planktonic bacteria, biofilms, and yeast. Laborious CFU experiments such as checkerboard assays, treatment time-courses, and drug screens against slow-growing cells are simplified by GVA. We therefore screened a drug library against exponential and stationary phase E. coli leading to the discovery of the ROS-mediated, bactericidal mechanism of diphenyliodonium. The ease and low cost of GVA evinces it can accelerate existing viability assays and enable measurements at previously impractical scales. |
format | Online Article Text |
id | pubmed-9881960 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cold Spring Harbor Laboratory |
record_format | MEDLINE/PubMed |
spelling | pubmed-98819602023-01-28 High Throughput Viability Assay for Microbiology Meyer, Christian T. Lynch, Grace K. Stamo, Dana F. Miller, Eugene J. Chatterjee, Anushree Kralj, Joel M. bioRxiv Article Counting viable cells is a universal practice in microbiology. The colony forming unit (CFU) assay has remained the gold standard to measure viability across disciplines; however, it is time-intensive and resource-consuming. Herein, we describe the Geometric Viability Assay (GVA) that replicates CFU measurements over 6-orders of magnitude while reducing over 10-fold the time and consumables. GVA computes a sample’s viable cell count based on the distribution of embedded colonies growing inside a pipette tip. GVA is compatible with gram-positive and -negative planktonic bacteria, biofilms, and yeast. Laborious CFU experiments such as checkerboard assays, treatment time-courses, and drug screens against slow-growing cells are simplified by GVA. We therefore screened a drug library against exponential and stationary phase E. coli leading to the discovery of the ROS-mediated, bactericidal mechanism of diphenyliodonium. The ease and low cost of GVA evinces it can accelerate existing viability assays and enable measurements at previously impractical scales. Cold Spring Harbor Laboratory 2023-01-04 /pmc/articles/PMC9881960/ /pubmed/36712102 http://dx.doi.org/10.1101/2023.01.04.522767 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator. |
spellingShingle | Article Meyer, Christian T. Lynch, Grace K. Stamo, Dana F. Miller, Eugene J. Chatterjee, Anushree Kralj, Joel M. High Throughput Viability Assay for Microbiology |
title | High Throughput Viability Assay for Microbiology |
title_full | High Throughput Viability Assay for Microbiology |
title_fullStr | High Throughput Viability Assay for Microbiology |
title_full_unstemmed | High Throughput Viability Assay for Microbiology |
title_short | High Throughput Viability Assay for Microbiology |
title_sort | high throughput viability assay for microbiology |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881960/ https://www.ncbi.nlm.nih.gov/pubmed/36712102 http://dx.doi.org/10.1101/2023.01.04.522767 |
work_keys_str_mv | AT meyerchristiant highthroughputviabilityassayformicrobiology AT lynchgracek highthroughputviabilityassayformicrobiology AT stamodanaf highthroughputviabilityassayformicrobiology AT millereugenej highthroughputviabilityassayformicrobiology AT chatterjeeanushree highthroughputviabilityassayformicrobiology AT kraljjoelm highthroughputviabilityassayformicrobiology |